Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
2006 2
2008 1
2009 1
2010 2
2011 1
2012 2
2013 2
2014 1
2015 5
2016 8
2017 9
2018 18
2019 24
2020 23
2021 34
2022 25
2023 12
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

161 results

Results by year

Filters applied: . Clear all
Page 1
Response.
Hozumi H, Kono M, Hasegawa H, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Yokomura K, Nakamura H, Suda T. Hozumi H, et al. Among authors: karayama m. Chest. 2021 Dec;160(6):e683-e685. doi: 10.1016/j.chest.2021.07.044. Chest. 2021. PMID: 34872693 No abstract available.
Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosis.
Naoi H, Suzuki Y, Mori K, Aono Y, Kono M, Hasegawa H, Yokomura K, Inoue Y, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Nakamura H, Suda T. Naoi H, et al. Among authors: karayama m. Thorax. 2022 Jul;77(7):727-730. doi: 10.1136/thoraxjnl-2021-218281. Epub 2022 Mar 30. Thorax. 2022. PMID: 35354649
A predictive model for acute exacerbation of idiopathic interstitial pneumonias.
Karayama M, Aoshima Y, Suzuki T, Mori K, Yoshizawa N, Ichikawa S, Kato S, Yokomura K, Kono M, Hashimoto D, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Goshima S, Inui N, Suda T. Karayama M, et al. Eur Respir J. 2023 May 5;61(5):2201634. doi: 10.1183/13993003.01634-2022. Print 2023 May. Eur Respir J. 2023. PMID: 36822633 Free PMC article.
Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial.
Fujisawa T, Hozumi H, Kamiya Y, Kaida Y, Akamatsu T, Kusagaya H, Satake Y, Mori K, Mikamo M, Matsuda H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T. Fujisawa T, et al. Among authors: karayama m. Respirology. 2021 Apr;26(4):370-377. doi: 10.1111/resp.13978. Epub 2020 Nov 11. Respirology. 2021. PMID: 33179395 Free article. Clinical Trial.
Six-week oral prednisolone therapy for immune-related pneumonitis: a single-arm phase II study.
Karayama M, Inui N, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Asada K, Uto T, Fujii M, Matsui T, Matsuura S, Hashimoto D, Toyoshima M, Ikeda M, Matsuda H, Inami N, Kaida Y, Funayama S, Ichikawa S, Goshima S, Suda T. Karayama M, et al. J Immunother Cancer. 2023 Jul;11(7):e007056. doi: 10.1136/jitc-2023-007056. J Immunother Cancer. 2023. PMID: 37500182 Free PMC article. Clinical Trial.
Prognostic Role of Interferon-λ3 in Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis-Associated Interstitial Lung Disease.
Fukada A, Fujisawa T, Hozumi H, Koda K, Akamatsu T, Oyama Y, Satake Y, Niwa M, Kaida Y, Matsuda H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Hashimoto D, Yoshida A, Gono T, Kuwana M, Yamano Y, Kondoh Y, Yamashita K, Maekawa M, Mori K, Inoue Y, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Inui N, Suda T. Fukada A, et al. Among authors: karayama m. Arthritis Rheumatol. 2023 Dec 25. doi: 10.1002/art.42785. Online ahead of print. Arthritis Rheumatol. 2023. PMID: 38146102
Transient leukocytopenia following combination therapy for COVID-19.
Tsuchiya K, Fujisawa T, Mochizuka Y, Takuma S, Oishi K, Endo Y, Tanaka Y, Fukada A, Watanabe H, Katsumata M, Aoshima Y, Inoue Y, Suzuki Y, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T. Tsuchiya K, et al. Among authors: karayama m. Respir Investig. 2022 Jan;60(1):158-161. doi: 10.1016/j.resinv.2021.09.007. Epub 2021 Oct 9. Respir Investig. 2022. PMID: 34649811 Free PMC article.
Pharmacokinetics, Safety, and Efficacy of Trastuzumab Deruxtecan with Concomitant Ritonavir or Itraconazole in Patients with HER2-Expressing Advanced Solid Tumors.
Takahashi S, Karayama M, Takahashi M, Watanabe J, Minami H, Yamamoto N, Kinoshita I, Lin CC, Im YH, Achiwa I, Kamiyama E, Okuda Y, Lee C, Bang YJ. Takahashi S, et al. Among authors: karayama m. Clin Cancer Res. 2021 Nov 1;27(21):5771-5780. doi: 10.1158/1078-0432.CCR-21-1560. Epub 2021 Aug 23. Clin Cancer Res. 2021. PMID: 34426442 Free PMC article. Clinical Trial.
Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis.
Mochizuka Y, Suzuki Y, Kono M, Hasegawa H, Hashimoto D, Yokomura K, Inoue Y, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura H, Suda T. Mochizuka Y, et al. Among authors: karayama m. Respirology. 2023 Aug;28(8):775-783. doi: 10.1111/resp.14523. Epub 2023 May 23. Respirology. 2023. PMID: 37221050
Prognostic significance of radiological pleuroparenchymal fibroelastosis in Mycobacterium avium complex lung disease: a multicentre retrospective cohort study.
Aono Y, Hozumi H, Kono M, Hashimoto D, Nakamura H, Yokomura K, Imokawa S, Shirai M, Akahori D, Inoue Y, Mori K, Karayama M, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T. Aono Y, et al. Among authors: karayama m. Thorax. 2023 Aug;78(8):825-834. doi: 10.1136/thorax-2022-219116. Epub 2022 Nov 11. Thorax. 2023. PMID: 36368892
161 results